SCHEMBL7909807

SCHEMBL7909807

CC(C)Oc1ncc(C(F)(F)F)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.39
CYP3A4 P08684 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
KMT2A Q03164 2/20 0.36
HPGD P15428 1/20 0.36
CYP3A5 P20815 1/20 0.36
MAPK1 P28482 1/20 0.35
SLC6A9 P48067 1/20 0.35
KDM4E B2RXH2 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CDK1 P06493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29837917 0.81 CYP1A2 (0.43) CYP3A4CYP1A2CYP2C19SMN1; SMN2KMT2A
SCHEMBL7916612 0.81 CYP1A2 (0.43) CYP3A4CYP1A2CYP2C19SMN1; SMN2KMT2A
SCHEMBL12863410 0.80 PTGS2 (0.41) PTGS2CYP3A4CYP1A2CYP2C19SMN1; SMN2
SCHEMBL17069263 0.80 CYP1A2 (0.54) CYP3A4CYP1A2CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL6502269 0.78 NPSR1 (0.44) PTGS2CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL24310763 0.78 PTGS2 (0.39) PTGS2CYP3A4CYP1A2CYP2C19SMN1; SMN2
SCHEMBL7917315 0.76 PTGS2 (0.48) PTGS2CYP3A4CYP1A2CYP2C19SMN1; SMN2
SCHEMBL7909812 0.75 ALDH1A1 (0.37) PTGS2CYP3A4CYP1A2CYP2C19ALDH1A1
SCHEMBL3553372 0.75 LRRK2 (0.33)
SCHEMBL7917480 0.74 LMNA (0.38) PTGS2CYP3A4CYP1A2CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225320-B1 TREATMENT OF PAIN, INFLAMMATION, MIGRAINE, EMESIS AND POSTTHERPETIC NEURALGIA MERCK SHARP & DOHME LTD. (GB) 2001-05-01 US disclosed
EP-0989987-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2000-04-05 EP disclosed
US-5929094-A NOVEL 3-((SUBSTITUTED) HETEROCYCLE),6-(SUBSTITUTED PHENYL)-1-OXASPIRO(4.4)NONANE DERIVATIVES; ANTAGONIZING THE EFFECT OF SUBSTANCE P BY ADMINISTERING TO BLOCK NEUROKININ-1 RECEPTORS; TREATING INFLAMMATION, MIGRAINE, EMESIS AND ASTHMA MERCK & CO., INC. (US) 1999-07-27 US disclosed
WO-1998054187-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 1998-12-03 WO disclosed
WO-1998017276-A1 HETEROARYL SPIROETHERCYCLOALKYL TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-04-30 WO disclosed